Literature DB >> 22901575

Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.

Viraj A Master1, S Mohammad A Jafri, Kelvin A Moses, Kenneth Ogan, David A Kooby, Keith A Delman.   

Abstract

PURPOSE: Open inguinal lymphadenectomy has been associated with significant postoperative morbidity. Recently, small series have demonstrated the feasibility and efficacy of endoscopic groin lymphadenectomy as an alternative to open surgery. Previously we reported the favorable results of our initial experience. Few reports of novel surgical methods include long-term complications. In this report we present a detailed analysis of immediate and long-term complications associated with the procedure using standardized complications reporting methodology including the Clavien classification.
MATERIALS AND METHODS: From September 2008 to December 2009, 29 patients underwent endoscopic groin dissection for inguinal lymphadenectomy. The indications for dissection were cutaneous malignancies of the genitourinary area and lower extremities. Endoscopic dissection was performed as previously published. Data were prospectively collected regarding patient demographics and minor/major complications during the perioperative period as well as long-term complications during 1 year. Complications were described using the Clavien classification as well as other complication profiles for open inguinal lymphadenectomy. Minor complications were defined as mild to moderate leg edema, seroma formation not requiring aspiration, minimal skin edge necrosis requiring no therapy and cellulitis managed with antibiotics. Major complications included death, sepsis, venous thromboembolism, re-exploration or other invasive procedures, severe leg edema interfering with ambulation, skin flap necrosis and rehospitalization.
RESULTS: A total of 41 endoscopic groin dissections (12 single session bilateral) were performed in 29 patients. Patient characteristics were median body mass index 30 kg/m(2) (range 19 to 53, mean 31.1), median age 61 years (range 16 to 86), median Charlson comorbidity score 4 (range 1 to 11) and median length of stay 1 day (range 1 to 14). Median followup was 604 days (range 177 to 1,172, mean 634). There were no perioperative mortalities. A total of 11 (27%) minor and 6 (14.6%) major complications occurred.
CONCLUSIONS: Complications from endoscopic minimally invasive lymphadenectomy have low clinical morbidity. Analysis of the immediate and long-term complication profile using standardized Clavien complications reporting reveals that this procedure is safe, even in patients with a high Charlson comorbidity score and body mass index. Major complications were most often infection requiring intravenous antibiotics.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22901575     DOI: 10.1016/j.juro.2012.06.038

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 2.  [Cervical, inguinal and abdominal lymphnode dissection].

Authors:  T W Kraus; K Suna; S Berkhoff; E Jäger; U Kraus-Tiefenbacher
Journal:  Chirurg       Date:  2013-07       Impact factor: 0.955

3.  Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial.

Authors:  James W Jakub; Alicia M Terando; Amod Sarnaik; Charlotte E Ariyan; Mark B Faries; Sabino Zani; Heather B Neuman; Nabil Wasif; Jeffrey M Farma; Bruce J Averbook; Karl Y Bilimoria; Jacob B Jake Allred; Vera J Suman; Travis E Grotz; Benjamin Zendejas; Jeffrey D Wayne; Douglas S Tyler
Journal:  J Am Coll Surg       Date:  2015-11-25       Impact factor: 6.113

4.  Morbidity and risk factors for complications of inguinal lymph node dissection in penile cancer.

Authors:  Antoine Jeanne-Julien; Olivier Bouchot; Stéphane De Vergie; Julien Branchereau; Marie-Aimée Perrouin-Verbe; Jérôme Rigaud
Journal:  World J Urol       Date:  2022-10-08       Impact factor: 3.661

Review 5.  Technical considerations to minimize complications of inguinal lymph node dissection.

Authors:  Manik K Gupta; Amar P Patel; Viraj A Master
Journal:  Transl Androl Urol       Date:  2017-10

6.  Nomograms to predict the presence and extent of inguinal lymph node metastasis in penile cancer patients with clinically positive lymph nodes.

Authors:  Xiang Zhou; Yan Zhong; Lebin Song; Yamin Wang; Yichun Wang; Qijie Zhang; Rong Cong; Chengjian Ji; Tongfu Yu; Ninghong Song
Journal:  Transl Androl Urol       Date:  2020-04

Review 7.  Inguinal lymph node dissection for penile cancer: a contemporary review.

Authors:  Jiasian Teh; Catriona Duncan; Liang Qu; Glen Guerra; Vignesh Narasimhan; Toan Pham; Nathan Lawrentschuk
Journal:  Transl Androl Urol       Date:  2020-12

8.  Endoscopic inguinal lymphadenectomy in penile cancer: case report and literature review.

Authors:  Juan Carlos Pérez Astigueta; Milagros Abad-Licham; Eloy Silva; Edgar Yan; Hugo Álvarez; Folker Agreda; Mariela Pow-Sang
Journal:  Ecancermedicalscience       Date:  2015-10-05

9.  Robotic bilateral inguinal lymphadenectomy in penile cancer, development of a technique without robot repositioning: a case report.

Authors:  Rene Sotelo; Marino Cabrera; Oswaldo Carmona; Robert de Andrade; Oscar Martin; Golena Fernandez
Journal:  Ecancermedicalscience       Date:  2013-09-26

10.  The first leg video endoscopic groin lymphadenectomy in vulvar cancer: A case report.

Authors:  Angelica Naldini; Cristiano Rossitto; Andrea Morciano; Giovanni Panico; Giuseppe Campagna; Pierluigi Paparella; Giovanni Scambia
Journal:  Int J Surg Case Rep       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.